How to Get Put on Ozempic for Weight Loss: A Comprehensive Guide

Last reviewed: June 20, 2026

Last updated: June 20, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injections reduce appetite through GLP-1 receptor activation in the brain, producing an average 15% body weight loss in clinical trials. Getting started requires understanding eligibility, finding a qualified provider, and choosing between brand-name and compounded options. PlexusDx streamlines this entire journey with transparent pricing and genetic-informed treatment plans.

Understanding Semaglutide and How It Works for Weight Loss

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed to treat type 2 diabetes. When used for weight management, it slows gastric emptying and activates satiety centers in the hypothalamus, reducing hunger signals and calorie intake. Clinical data shows patients on semaglutide consume approximately 500 fewer calories daily compared to placebo groups.

The medication works by mimicking the natural hormone that regulates blood sugar and appetite. Unlike appetite suppressants that stimulate the nervous system, semaglutide targets the body's existing hunger-control pathways. This mechanism makes it effective for sustained weight loss rather than temporary appetite suppression, with benefits continuing as long as treatment continues.

Medical Eligibility and Screening Requirements for Semaglutide

Most candidates for semaglutide meet basic criteria: a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with weight-related health conditions such as hypertension, prediabetes, or sleep apnea. Age typically ranges from 18 to 75, though older patients may qualify with additional screening. A comprehensive medical history and current medication review are essential to rule out contraindications.

Certain conditions disqualify patients from semaglutide therapy, including personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2, severe kidney or liver disease, and active diabetic retinopathy. Pregnancy and breastfeeding are absolute contraindications. PlexusDx providers conduct detailed intake assessments to ensure safety before any medication is dispensed.

Navigating Your Semaglutide Prescription and Dosing Options

Semaglutide treatment typically begins at a low dose to minimize gastrointestinal side effects, then increases gradually every 4 weeks until reaching your optimal maintenance dose. Most patients progress from 0.25 mg to a maintenance range of 1.0–2.4 mg weekly. The phrase 'your dose may need to go up, your price won't' reflects PlexusDx's flat-rate pricing model—medication cost remains consistent regardless of which dose strength you require.

Compounded semaglutide injections from PlexusDx are $189/mo month-to-month, or from $149/mo on the 6-month plan and maintain that price whether you're on a starter dose or a higher maintenance level. Patients also have the option of oral semaglutide tablets, which offer convenience for those uncomfortable with injections. Both delivery methods are formulated by licensed 503A compounding pharmacies and require no insurance, making them accessible in all 50 states.

Personalizing Your Treatment with Genetic Insights

The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Understanding your genetic profile allows your PlexusDx provider to recommend the most effective compound for your biology. Some patients achieve superior results with semaglutide alone, while others benefit from dual-compound formulas like GLP-Squared, which combines semaglutide and tirzepatide. The Precision Peptide Genetic Test costs $298.

Cost and Access: Why Compounded Semaglutide May Be Your Best Option

Brand-name semaglutide (Ozempic, Wegovy) can cost $800–$1,500 monthly with insurance or $1,500–$2,000 out-of-pocket. PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan, with no membership fees, no insurance required, and HSA/FSA eligibility. This dramatic price difference is possible because compounded medications bypass manufacturer markups while maintaining the same active ingredient and quality standards.

All PlexusDx medications come from licensed 503A compounding pharmacies verified to follow strict USP <797> standards for sterility, potency, and purity. Patients can choose from three commitment tiers that fit their budget, and pricing remains flat across dose increases. PlexusDx also offers microdose GLP-1 protocols starting at $129 monthly for patients seeking a gentler entry point into treatment.

Common Side Effects and How to Manage Them

The most frequent side effect is nausea, reported by 25–40% of patients in the first 2–4 weeks as the dose ramps up. Other common effects include constipation, diarrhea, vomiting, and fatigue, which typically improve as the body adapts. Starting at a low dose and increasing slowly—the standard titration schedule—significantly reduces symptom severity. Eating smaller, lower-fat meals and staying hydrated also minimize gastrointestinal distress.

Severe side effects are rare but require immediate medical attention: signs of pancreatitis (severe upper abdominal pain), vision changes, rapid heartbeat, or signs of thyroid cancer (persistent hoarseness, difficulty swallowing, neck swelling). PlexusDx providers monitor patients throughout treatment and adjust dosing or recommend alternative therapies if intolerance develops. Most patients continue treatment successfully because side effects are manageable with proper support.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

Do I need insurance or a traditional doctor to get semaglutide from PlexusDx?

No. PlexusDx serves all 50 states with no insurance requirement, membership fees, or need for a prior prescription. You complete a medical intake with a qualified provider, receive a personalized treatment plan, and have compounded semaglutide shipped directly to you. HSA and FSA accounts are accepted.

How does compounded semaglutide compare to brand-name Ozempic or Wegovy?

Compounded semaglutide contains the identical active ingredient as brand-name versions but costs a fraction of the price because it bypasses manufacturer markups. PlexusDx sources all compounds from licensed 503A pharmacies that follow strict USP standards. The clinical efficacy is the same; the difference is in cost and accessibility.

What if my dose needs to increase? Will my price change?

No. PlexusDx uses flat-rate pricing: semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan and remain that price regardless of whether you increase your dose. This model ensures your cost stays predictable even as your treatment evolves.

Are compounded medications as safe as FDA-approved versions?

Compounded medications are not FDA-approved, but they are regulated and verified for safety. PlexusDx uses only licensed 503A compounding pharmacies—never 503B—that follow USP <797> standards for sterility, potency, and purity. Your provider monitors you throughout treatment to ensure safety.

What is the PlexusDx Precision Peptide Genetic Test and how does it help?

This $298 test identifies genetic variants in GIPR and FTO, and MC4R genes that influence how your body responds to semaglutide and other weight loss peptides. It maps 49 peptides across 14 pathways to reveal your optimal treatment compound—whether that's semaglutide alone, tirzepatide, or a dual-compound formula like GLP-Squared.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Weight Loss Drugs Like Ozempic
• Ozempic Weight Loss Before And After Pictures

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.